MammoSite®, a delivery system for partial breast irradiation, appears to be an effective treatment for early-stage breast cancer. These findings were recently published in the journal Cancer. Read the rest of this entry »

Among women, breast cancer is the most common cause of cancer death. Each year nearly 180,000 women in the United States are diagnosed with breast cancer. More than 40,000 a year die from this disease. Read the rest of this entry »

One Tri-state doctor’s office provides a new way to screen for breast cancer that could detect problems up to eight years before a mammogram. Read the rest of this entry »

A revolutionary test that detects the first signs of breast cancer from a few strands of a woman’s hair could be on sale within months. Read the rest of this entry »

 Fujifilm has announced the FCR Digital Mammography CAD MV-SR657, a computer support system for the detection of breast cancer. Read the rest of this entry »

AviaraDx, Inc., has launched two new oncology tests for classifying metastatic cancer and identifying patients with estrogen receptor positive (ER+) breast cancer who are at high risk of recurrence as well as unlikely to respond favorably to standard adjuvant endocrine therapy. Read the rest of this entry »

A Phoenix company is now offering a blood test for early detection of breast cancer in Arizona patients. Read the rest of this entry »

A medical imager that detects and guides the biopsy of breast cancer lesions can spot tumors half the size detected by current imagers, a U.S. study found. Read the rest of this entry »

Women who live in Chicago’s gentrifying neighborhoods are more apt to receive a late diagnosis of breast cancer than women who live in poverty-stricken neighborhoods, University of Illinois at Chicago researchers have found. Read the rest of this entry »

Provista Life Sciences LLC, a diagnostic development and commercialization company based in Phoenix, on Tuesday announced the availability of its blood test for early detection of breast cancer in Arizona patients. Read the rest of this entry »

Pathology reports offer a fairly accurate alternative to repeated testing in a central laboratory for determining estrogen receptor status in large epidemiologic studies of women with breast cancer. Read the rest of this entry »

News for the Cure - Breast Screening Technologies

Suspicious breast mass? Learn the importance of re-screening during the diagnostic process and the benefits of new imaging technologies.

News for the Cure - Breast Screening Technologies

IPSOGEN SAS has announced the signature of a license agreement with Universite Libre de Bruxelles (ULB), Belgium for the worldwide and exclusive rights on the Genomic Grade™.
Read the rest of this entry »

Although chemotherapy is recommended for many women with early-stage breast cancer, the benefit of chemotherapy varies. Identifying in advance those women who are most likely to benefit from chemotherapy may allow for more-individualized treatment. This would allow women who are unlikely to benefit from chemotherapy to avoid the toxic effects of treatment. Read the rest of this entry »

AUSTRALIAN women could be tested for breast cancer through the strands of their hair using a new screening method later this year. Read the rest of this entry »

Three in 10 women aged 50-70 are not receiving breast cancer screening every three years, despite government targets.

New figures published by the Department of Health last week show that just under 70 per cent of women in this age group are being screened despite the government’s 2000 NHS cancer plan target of breast screening every three years being available on the NHS to all women aged 50 and over. The statistics also show a huge disparity in screening across the country.

http://www.hsj.co.uk/news/2008/01/breast_cancer_screening.html 

A new study shows the higher out-of-pocket costs of mammograms are preventing some women from having them.